Bridgeway Capital Management’s Biodesix BDSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.7K | Hold |
137,011
| – | – | ﹤0.01% | 1144 |
|
|
2025
Q1 | $85.7K | Sell |
137,011
-257,300
| -65% | -$161K | ﹤0.01% | 1066 |
|
|
2024
Q4 | $603K | Buy |
394,311
+109,800
| +39% | +$168K | 0.01% | 776 |
|
|
2024
Q3 | $506K | Buy |
284,511
+99,448
| +54% | +$177K | 0.01% | 857 |
|
|
2024
Q2 | $283K | Sell |
185,063
-44,600
| -19% | -$68.2K | 0.01% | 976 |
|
|
2024
Q1 | $328K | Buy |
229,663
+463
| +0.2% | +$662 | 0.01% | 1021 |
|
|
2023
Q4 | $422K | Buy |
229,200
+49,200
| +27% | +$90.5K | 0.01% | 981 |
|
|
2023
Q3 | $297K | Sell |
180,000
-50,000
| -22% | -$82.5K | 0.01% | 1012 |
|
|
2023
Q2 | $283K | Buy |
230,000
+50,600
| +28% | +$62.2K | 0.01% | 1061 |
|
|
2023
Q1 | $334K | Buy |
179,400
+104,400
| +139% | +$194K | 0.01% | 984 |
|
|
2022
Q4 | $173K | Sell |
75,000
-25,000
| -25% | -$57.5K | ﹤0.01% | 1117 |
|
|
2022
Q3 | $127K | Buy |
100,000
+50,000
| +100% | +$63.5K | ﹤0.01% | 1229 |
|
|
2022
Q2 | $82K | Sell |
50,000
-35,000
| -41% | -$57.4K | ﹤0.01% | 1247 |
|
|
2022
Q1 | $144K | Sell |
85,000
-20,000
| -19% | -$33.9K | ﹤0.01% | 1224 |
|
|
2021
Q4 | $555K | Buy |
+105,000
| New | +$555K | 0.01% | 951 |
|